Omar Bagasra

Bagasra was born on the border of Pakistan and India in the royal state of Junagadh in 1948 at the eve of Indo-Pak partition and Pakistani independence, while his family immigrated to their new homeland, Pakistan. He came from a Memon businessmen family, born in the household of Mr. Habib Ahmed Bagasra and Mrs Amina Habib. The family settled in Karachi after their arrival in Pakistan, where he had his early and higher secondary schooling from Karachi. He completed his Bachelors in Microbiology and Masters in Biochemistry, both from the University of Karachi, in 1968 and 1970, respectively. He proceeded to United States to do his doctorate in the early seventies, completing his Ph.D. in Microbiology & Immunology, from the University of Louisville, Louisville, Kentucky in 1979. Finally, his long-standing interest in medicine motivated him to pursue a career in medicine by enrolling and completing his Doctor of Medicine (MD) from the Universidad Autónoma de Ciudad Juárez in 1985. He completed his residency in pathology from the Temple University School of Medicine in 1993 and a string of fellowships in Clinical Laboratory Immunology and Infectious Disease from Temple University, Philadelphia and the Albany Medical College, New York, respectively.

His graduate advisors included John H. Wallace (University of Louisville, KY), John M Mansfield (University of Louisville, KY), and Harold W. Lischner (Temple University, PA).

He is currently a tenured Professor of Biology (and the Director) at the South Carolina Center for Biotechnology,Claflin University, as well as a Clinical Professor of Pathology, Microbiology and Immunology, with the University of South Carolina School of Medicine. He is also an Adjunct Professor with a number of reputed medical schools, most notably the Department of Epidemiology & Biostatistics, Univ. of South Carolina. He is also a reviewer with one of the most reputed journals of science, the Science (magazine).

He is author of two well-known books in Biotechnology, 'HIV and Molecular Immunity' and 'In-situ PCR Technique', latter with his co-author as John Hansen.

Other than his services to medicine and his innovative techniques in biotechnology, he is known for his role as a reviewer and investigator of the notorious HIV trial in Libya, where, allegedly, some children were injected with the virus for AIDS, the HIV, by some local and expatriate medical staff working then in Libya. His investigation was pivotal in the outcome of the exonerating decision against the accused.

His most notable student so far is Mazhar Kanak, MD, PhD, who is an Assistant Professor, VCU School of Medicine Department of Surgery (in the Division of Transplant Surgery), as well as the Assistant Director of the Islet Cell Transplant Lab, an important pioneering lab in the area of Islet cells, both at the Virginia Commonwealth University.

He has one son, an infectious diseases specialist, and a daughter who is a psychology professor.

He is currently involved with the development and critique of various bona fide endeavors in finding a viable vaccine for the Zika virus, in addition to working on a new experimental diagnostic kit which, he claims, will replace field diagnostic kits.

He devised a modified form of the Nobel awarded Polymerase Chain Reaction (PCR) technique, for which a patent is owned by him (U.S. Patent #5,589,333, issued Dec. 31, 1996. In situ PCR- Basic Technology).

His other major patents include:

1998 U.S. Patent #5,750,347, issued May 12, 1998. In situ PCR- Automation Technology.

2006 Genetically engineered Pyrococcus furosis microorganism to produce bio-fuels and other chemicals from carbohydrates in a single bioreactor.

2007 Genetically engineered thermophile/hyperthermophile microorganism to produce bio-fuels and other chemicals from carbohydrates in a single bioreactor

2008 U.S. Patent # 021396/0640 August 15, 08 miRNA Triplex Formations for the downregulation of HIV replication.

2008 U.S. Patent # 018293-00006 Hyperthermophile microorganisms to produce Bio-Fuels and other chemicals from carbohydrates in a single bioreactor.

2009 U.S. Patent #018293.000006D. Fusion of Bacterial Protoplast of Clostritridium Spps. to Produce Biofuel.

2010 U.S. Patent. Fusion of Bacterial Protoplasts of Five Strains of Clostridium to Produce a Unique Thermophilic that Produces Bio-fuels and Other Chemicals Like Butanole in a Single Bioreactor.

2012 U.S Patent # 018293.00016 HIV replication inhibition using viral gene fragments and homologous microRNAs.

2014 U.S. Patent (#8,669,082 B1). Methods of Producing Butanol by a Unique Thermophile that Produces Biofuels from Lignocellulosic Biomass.

He is a recipient of a number of awards and honors, which most notably include, as follows;

1995: Nomination for the “King Faisal Award in Medicine”

2002: Recipient of the AACR Faculty Scholar Award in Cancer Research

2004: Nomination for the 2005 Governor’s Awards for Excellence in Science

2005: Received the Outstanding Teacher Award by Claflin University.

2005: Elected “member of the Nominating Committee for the 2005-2006 AACR-MICR-Jane Cook Wright Lectureship.”

2006: Co-Winner of the South Carolina Governor’s Award for Science Awareness

2006: Winner of the Link Award

2008 Winner of James E. Hunter Award for outstanding performance in teaching & Educational Development. Claflin University May 10 08.

2010: Nominated for “The 2010 Louisa Gross Horwitz Prize for Biology or Biochemistry” Award

2011: Recognition Certification from the American Society of Microbiology for “Outstanding Service to Minority Mentoring Program

2012: Winner of the First James E. Clyburn Health Disparities Leadership Award

2014: Winner of Attorney William H. and Annette B. Johnson Endowed Annual Faculty Award for Innovative Scientific Research